loading...| Preferred Name |
Rifamycin |
|
| Synonyms |
|
|
| Definitions |
A natural antibiotic produced by Streptomyces mediterranei, Rifamycin (Ansamycin Family) is a commonly used antimycobacterial drug that inhibits prokaryotic DNA-dependent RNA synthesis and protein synthesis; it blocks RNA-polymerase transcription initiation. Rifamycin has an activity spectrum against Gram-positive and Gram-negative bacteria, but is mainly used against Mycobacterium sp. (especially M. tuberculosis) in association with other agents to overcome resistance. (NCI04) |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C29406 |
|
| Accepted_Therapeutic_Use_For |
Treatment of traveler's diarrhea |
|
| CAS_Registry |
6998-60-3 |
|
| CHEBI_ID |
CHEBI:26580 |
|
| Chemical_Formula |
C37H47NO12 |
|
| code |
C29406 |
|
| Contributing_Source |
FDA |
|
| definition |
A natural antibiotic produced by Streptomyces mediterranei, Rifamycin (Ansamycin Family) is a commonly used antimycobacterial drug that inhibits prokaryotic DNA-dependent RNA synthesis and protein synthesis; it blocks RNA-polymerase transcription initiation. Rifamycin has an activity spectrum against Gram-positive and Gram-negative bacteria, but is mainly used against Mycobacterium sp. (especially M. tuberculosis) in association with other agents to overcome resistance. (NCI04) |
|
| FDA_UNII_Code |
DU69T8ZZPA |
|
| Has_Salt_Form | ||
| in_subset | ||
| label |
Rifamycin |
|
| Legacy Concept Name |
Rifamycin |
|
| NCI_META_CUI |
CL560681 |
|
| NSC Number |
133100 145604 |
|
| Preferred_Name |
Rifamycin |
|
| prefixIRI |
NCIT:C29406 |
|
| prefLabel |
Rifamycin |
|
| Semantic_Type |
Pharmacologic Substance |
|
| subClassOf |